CALA (Calithera Biosciences) Liabilities-to-Assets : 0.29 (As of Dec. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Calithera Biosciences Liabilities-to-Assets?

Calithera Biosciences CALA Liabilities-to-Assets is 0.29 as of Dec. 2022.

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Calithera Biosciences's Total Liabilities for the quarter that ended in Dec. 2022 was $8.28 Mil. Calithera Biosciences's Total Assets for the quarter that ended in Dec. 2022 was $28.68 Mil. Therefore, Calithera Biosciences's Liabilities-to-Assets Ratio for the quarter that ended in Dec. 2022 was 0.29.

Calithera Biosciences  (OTCPK:CALA) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.

Calithera Biosciences Liabilities-to-Assets Related Terms

Calithera Biosciences Liabilities-to-Assets Historical Data

* Premium members only.

The historical data trend for Calithera Biosciences's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Calithera Biosciences Liabilities-to-Assets Chart

Calithera Biosciences Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Liabilities-to-Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.11 0.16 0.19 0.87 0.29

Calithera Biosciences Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Liabilities-to-Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.87 1.06 0.23 0.29 0.29

CALA vs PPCB, QBIO, RGMP: Liabilities-to-Assets Comparison

For the Shell Companies subindustry, Calithera Biosciences's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Calithera Biosciences Liabilities-to-Assets vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Calithera Biosciences's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Calithera Biosciences's Liabilities-to-Assets falls into.


Calithera Biosciences Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Calithera Biosciences's Liabilities-to-Assets Ratio for the fiscal year that ended in Dec. 2022 is calculated as:

Liabilities-to-Assets (A: Dec. 2022 )=Total Liabilities/Total Assets
=8.284/28.676
=0.29

Calithera Biosciences's Liabilities-to-Assets Ratio for the quarter that ended in Dec. 2022 is calculated as

Liabilities-to-Assets (Q: Dec. 2022 )=Total Liabilities/Total Assets
=8.284/28.676
=0.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Liabilities-to-Assets →
What does a Liabilities-to-Assets of 0.29 mean?
Calithera Biosciences (CALA) has a Liabilities-to-Assets of 0.29 as of Dec. 2022. Liabilities-to-Assets equals total liabilities divided by total assets. It measures financial leverage. View historical data on Calithera Biosciences and its competitors.
Is Calithera Biosciences' Liabilities-to-Assets too high?
Calithera Biosciences' current Liabilities-to-Assets is 0.29.
How does Calithera Biosciences' Liabilities-to-Assets compare to PPCB and QBIO?
Calithera Biosciences' Liabilities-to-Assets of 0.29 can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Liabilities-to-Assets for a Diversified Financial Services company?
A good Liabilities-to-Assets depends on the Diversified Financial Services industry context. However, Liabilities-to-Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Liabilities-to-Assets mean?
A high Liabilities-to-Assets can signal that a stock is expensive relative to its fundamentals. Liabilities-to-Assets equals total liabilities divided by total assets. It measures financial leverage. View historical data on Calithera Biosciences and its competitors. Calithera Biosciences's current Liabilities-to-Assets is 0.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Calithera Biosciences stock overvalued right now?
Calithera Biosciences (CALA) has a current Liabilities-to-Assets of 0.29. The current Liabilities-to-Assets is 0.29. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Liabilities-to-Assets calculated?
Liabilities-to-Assets is calculated from a company's financial statements. For Calithera Biosciences (CALA), the current Liabilities-to-Assets is 0.29 as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Calithera Biosciences Business Description

Address 343 Oyster Point Boulevard, Suite 200, South San Francisco, CA, USA, 94080
Calithera Biosciences Inc is a shell company.